Clinical Trials · NCT06803888

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Phase
Phase 4
Recruitment status
Active Not Recruiting
Sponsor
Ali Aminian
Enrollment
125
Start date
Jan 2025
Locations
1 site, United States
Primary endpoint
The mean percentage weight loss
View Tirzepatide compound reference